These products are not intended for human or veterinary administration
Back Elrick, H., Stimmler, L, Arai, Y (1964) 'Plasma insulin response to oral and intravenous glucose administration', Journal Clinical Endocrinology Metabolism , 24/10, 107682
Traditional weight loss interventions like very-low-calorie diets, behavioral modification programs, and over-the-counter supplements have a substantially weaker evidence base than prescription GLP-1 medications for sustained, clinically significant weight loss that persists beyond the active intervention period - a distinction that matters when you're evaluating whether a monthly subscription to a medication program is a better long-term value than another round of a protocol you've already tried and discontinued
Clin Pharmacokinet (2016) 55(6):65772
GMP: Good Manufacturing Practice
But Semaglutide has a longer track record of use, widespread availability, and more insurance coverage options through brands like Ozempic and Wegovy